SIBIONICS a PharmaSens skúmajú na EASD 2026 nové možnosti automatizovaného podávania inzulínu

ConferencePositive

AI Analysis

Summary

SiBionics and PharmaSens presented on automated insulin delivery and continuous glucose monitoring at the European Association for the Study of Diabetes (EASD) 2026 conference, showcasing integrated diabetes care solutions.

Importance:3/10

Sentiment:

0.30

diabetesinsulin deliveryautomatedcontinuous monitoringEASD 2026conference presentation

Read the original article

Published by PR Newswire Pharma on October 4, 2026 6:55 PM

Read Original